Prime Medicine, Common Etf Alpha and Beta Analysis
| PRME Etf | USD 1.79 0.07 4.07% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Prime Medicine, Common. It also helps investors analyze the systematic and unsystematic risks associated with investing in Prime Medicine, over a specified time horizon. Remember, high Prime Medicine,'s alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Prime Medicine,'s market risk premium analysis include:
Beta 2.8 | Alpha (0.28) | Risk 5.65 | Sharpe Ratio (0.12) | Expected Return (0.70) |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Prime |
Prime Medicine, Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Prime Medicine, market risk premium is the additional return an investor will receive from holding Prime Medicine, long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Prime Medicine,. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Prime Medicine,'s performance over market.| α | -0.28 | β | 2.80 |
Prime Medicine, expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Prime Medicine,'s Buy-and-hold return. Our buy-and-hold chart shows how Prime Medicine, performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Prime Medicine, Market Price Analysis
Market price analysis indicators help investors to evaluate how Prime Medicine, etf reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Prime Medicine, shares will generate the highest return on investment. By understating and applying Prime Medicine, etf market price indicators, traders can identify Prime Medicine, position entry and exit signals to maximize returns.
Prime Medicine, Return and Market Media
The median price of Prime Medicine, for the period between Sun, Dec 15, 2024 and Sat, Mar 15, 2025 is 2.84 with a coefficient of variation of 13.04. The daily time series for the period is distributed with a sample standard deviation of 0.36, arithmetic mean of 2.77, and mean deviation of 0.28. The Etf received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Prime Medicines SWOT analysis gene editing firms stock faces pivotal 2025 | 12/17/2024 |
2 | Is Prime Medicine Among the Top CRISPR Stocks to Invest In | 12/31/2024 |
3 | Disposition of 471 shares by Gv 2019 Gp, L.l.c. of Prime Medicine, at 14.7534 subject to Rule 16b-3 | 01/08/2025 |
4 | A Comparison Between Qiagen and Prime Medicine | 02/19/2025 |
5 | Acquisition by Reine Allan of 275000 shares of Prime Medicine, at 2.42 subject to Rule 16b-3 | 02/27/2025 |
6 | Prime Medicine Inc Reports Q4 Revenue of 2. ... | 02/28/2025 |
7 | Acquisition by Schenkein David P of 062 shares of Prime Medicine, at 14.83 subject to Rule 16b-3 | 03/10/2025 |
About Prime Medicine, Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Prime or other etfs. Alpha measures the amount that position in Prime Medicine, Common has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Prime Medicine, Upcoming Company Events
As portrayed in its financial statements, the presentation of Prime Medicine,'s financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Prime Medicine,'s leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Prime Medicine,'s public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Prime Medicine,. Please utilize our Beneish M Score to check the likelihood of Prime Medicine,'s management manipulating its earnings.
| 14th of March 2024 Upcoming Quarterly Report | View | |
| 9th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 14th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Prime Medicine,
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Other Information on Investing in Prime Etf
Prime Medicine, financial ratios help investors to determine whether Prime Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Prime with respect to the benefits of owning Prime Medicine, security.